MARKET

MDVL

MDVL

MedAvail Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.40
-0.20
-1.14%
Closed 16:00 11/30 EST
OPEN
20.79
PREV CLOSE
17.60
HIGH
20.79
LOW
17.03
VOLUME
55.68K
TURNOVER
--
52 WEEK HIGH
46.20
52 WEEK LOW
8.89
MARKET CAP
551.58M
P/E (TTM)
-4.0876
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
CVS Health, Walgreens Boots Alliance among major healthcare premarket losers' pack
Brainstorm Cell Therapeutics (BCLI) -69% after announcing topline results from Phase 3 trial evaluating NurOwn.Alterity Therapeutics (ATHE) -24%.iBio (IBIO) -20% on FQ1 earnings release.The Alkaline Water Company (WTER) -17% on FQ2 earnings release.GoodRx Holdings (GDRX) -18% tumble after
Seekingalpha · 11/17 14:01
MYOS RENS Technology Board Of Directors Approved The Reverse Stock Split Ratio Of One New Share For Every 12 Shares Of Common Stock Outstanding
CEDAR KNOLLS, N.J., Nov. 17, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ:MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a
Benzinga · 11/17 13:12
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS)
PR Newswire · 11/17 13:00
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS)
PR Newswire · 11/12 21:30
MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance
MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), "The Muscle Health Company" and owner of the advanced nutrition supplement Fortetropin®, announced today that it has hired The S3 Agency (S3). The Boonton-based creative agency will be executing an integrated public relations-social
PR Newswire · 09/09 13:00
Shares of several technology companies are trading lower, potentially amid profit taking following the sector's recent run. Seeing possible rotation into other sectors for the session amid market volatility after Trump signed orders extending coronavirus relief measures.
Benzinga · 08/10 18:35
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, is investigating:
PR Newswire · 08/09 11:17
WeissLaw LLP Reminds MJCO and MYOS Shareholders About Its Ongoing Investigations
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
PR Newswire · 08/08 02:12
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MDVL. Analyze the recent business situations of MedAvail Holdings Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Price Target
The average MDVL stock price target is 3.750 with a high estimate of 3.750 and a low estimate of 3.750.
EPS
Institutional Holdings
Institutions: 19
Institutional Holdings: 36.06K
% Owned: 0.11%
Shares Outstanding: 31.70M
TypeInstitutionsShares
Increased
1
63
New
8
-14.33K
Decreased
1
859
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Industrial Machinery & Equipment
-1.01%
Machinery, Equipment & Components
-0.77%
Key Executives
Chairman/Director
Gerard van Hamel Platerink
President/Chief Executive Officer/Director
Edwin Kilroy
Chief Financial Officer/Treasurer/Secretary
Ryan Ferguson
Chief Information Officer
Fraser Mackay
Chief Marketing Officer
Will Misloski
Other
Neil Prezioso
Other
Dave Rawlins
Director
Robert Faulkner
Independent Director
Helen Ciesielski
Independent Director
Gerald Gradwell
Independent Director
Michael Kramer
Independent Director
Glen Stettin
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MDVL
Medavail Holdings Inc., formerly MYOS RENS Technology Inc., is a healthcare company. The Company is focused on developing and commercializing a self-service pharmacy, mobile app, kiosk and drive-thru solution. The Company’s wholly-owned subsidiary is MedAvail Inc (MedAvail). MedAvail is a telehealth-enabled pharmacy-technology company that brings access to pharmacy services and pharmacists directly into the care clinic. It offers MedAvail MedCenter kiosk and software that enables patients to access remote pharmacy team via a live audio-visual connection.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Medavail Holdings Inc stock information, including NASDAQ:MDVL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDVL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MDVL stock methods without spending real money on the virtual paper trading platform.